With Congress extending the Acute Hospital Care at Home waiver through 2030, the focus for program leaders has shifted from patient interest to long-term adherence.
While 72% of acute patients express a willingness to use wearables for home recovery, the primary concern remains whether they will consistently wear the devices.
To explore this, we conducted a survey with 350 respondents managing cancer-related and cardiovascular conditions.
Vivalink is a provider of digital healthcare solutions for remote patient monitoring in healthcare and clinical trials. By combining medical wearables, advanced algorithms, and clinical applications, we provide a more effective and accessible approach to patient care worldwide.
Copyright ©2026 VivaLNK, Inc. All Rights Reserved | Privacy Policy